Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joanna Jaroch.
Cardiology Journal | 2013
Maria Łoboz-Rudnicka; Joanna Jaroch; Zbigniew Bociąga; Ewa Kruszyńska; Barbara Ciecierzyńska; Magdalena Dziuba; Krzysztof Dudek; Izabela Uchmanowicz; Krystyna Łoboz-Grudzień
BACKGROUNDnWe aimed at establishing if the substitution of vascular age (VA) for chronological age (CA) causes a change in the Framingham Risk Score (FRS) categories. Sex differences in predictors of increased VA among cardiovascular (CV) risk factors and arterial stiffness (AS) parameters were identifi ed.nnnMETHODSnIn 187 asymptomatic subjects with CV risk factors, classifi ed into 3 FRS categories the VA was derived from the nomograms of the carotid intima-media thickness. Two groups: 1 - subjects whose VA has exceeded CA for at least 5 years and 2 - others were established. Carotid AS parameters were obtained from echo-tracking.nnnRESULTSnSubstitution of VA for CA changed the FRS category into the higher one in 11.8% of subjects. Diabetes mellitus (DM) was the predictor of increased VA in both sexes, while metabolic syndrome (MS) only in women. The cut-off values of AS parameters that allow for prediction of increased VA were determined from the ROC-curve analysis - in men: b > 7.3, Ep > 103 kPa, AC < 0.61 mm2/kPa after adjustment for DM, BMI > 29.1 kg/m2, WHR > 0.85 and CA > 51 years; in women: b > 9.6, Ep > 126 kPa, AC < 0.75 mm2/kPa, PWV-b > 7.4 m/s after adjustment for DM, BMI > 25.8 kg/m2, WHR > 0.80 and CA > 60 years.nnnCONCLUSIONSnThe substitution of VA for CA may increase the FRS category. Sex differences in predictors of increased VA were identifi ed. AS parameters proved to be predictors of increased VA besides the classic risk factors.
Advances in Clinical and Experimental Medicine | 2016
Joanna Jaroch; Krystyna Łoboz-Grudzień; Stefania Magda; Maria Florescu; Zbigniew Bociąga; Andrea O. Ciobanu; Ewa Kruszyńska; Krzysztof Dudek; Dragos Vinereanu
BACKGROUNDnLeft ventricular hypertrophy (LVH) and geometry patterns vary in different hemodynamic profiles The concentric hypertrophy (CH) pattern has been proved to have the worst prognosis.nnnOBJECTIVESnThe aim of the study was to test the hypothesis that carotid artery stiffness, as a marker of vascular damage, is associated with CH, independently of other potential determinants such as demographic factors (age, sex, BMI), clinical parameters (smoking, diabetes, creatinine level) and hemodynamic variables (blood pressure, pulse pressure [PP]).nnnMATERIAL AND METHODSnThe study involved 262 subjects (89 men): 202 patients with hypertension (153 untreated, 49 on medication), aged 55.7 ± 10 years, and 60 age-matched normal controls. The subjects were examined by echocardiography and carotid ultrasound with a high-resolution echo-tracking system. Based on the left ventricular mass index (LVMI) and relative wall thickness (RWT), the patients with hypertension were divided into four patterns of LVH and geometry: normal geometry (N, n = 57), concentric remodeling (CR, n = 48), concentric hypertrophy CH (n = 62) and eccentric hypertrophy (EH, n = 35). Intima-media thickness (IMT) and the parameters of arterial stiffness were also assessed using the β stiffness index (β), Young elastic modulus (Ep), arterial compliance (AC), one-point pulse wave velocity (PWVβ) and the wave reflection augmentation index (AI).nnnRESULTSnUnivariate analysis showed that the following variables are significant in determining CH: β > 8.4, Ep > 136 kPa, PWVβ > 7.1 m/s, AI > 21.9%, systolic BP > 151 mm Hg, PP > 54, IMT > 0.56 and the presence of diabetes. However, by multivariate analysis only AI (OR 3.65, p = 0.003), PWVβ > 7.1 m/s (OR 2.86, p = 0.014), systolic BP (OR 3.12, p = 0037) and the presence of diabetes (OR 3.75, p = 0.007) were associated independently with the occurrence of CH.nnnCONCLUSIONSnConcentric hypertrophy in hypertension is strongly associated with carotid arterial stiffness and wave reflection parameters, independently of the influence of systolic blood pressure and diabetes.
Kardiologia Polska | 2012
Joanna Jaroch; Krystyna Łoboz−Grudzień; Zbigniew Bociąga; Alicja Kowalska; Ewa Kruszyńska; Małgorzata Wilczyńska; Krzysztof Dudek
Cardiology Journal | 2007
Krystyna Łoboz-Grudzień; Alicja Kowalska; Barbara Brzezińska; Leszek Sokalski; Joanna Jaroch
Cardiology Journal | 2011
Krystyna Łoboz-Grudzień; Joanna Jaroch
Cardiology Journal | 2009
Krystyna Łoboz-Grudzień; Joanna Jaroch
Kardiologia Polska | 2003
Andrzej Wojszwiłło; Krystyna Łoboz-Grudzień; Joanna Jaroch
Folia Cardiologica | 2015
Joanna Jaroch; Maria Kuśnierz; Alicja Sołtowska; Izabella Uchmanowicz
Folia Cardiologica | 2005
Joanna Jaroch; Krystyna Łoboz-Grudzień; Marzena Stopyra-Początek; Alicja Kostecka-Pokryszko i Ewa Kruszyńska
Archive | 2004
Folia Cardiol; Alicja Kostecka-Pokryszko; Joanna Jaroch